Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Cysteamine"" wg kryterium: Temat


Tytuł :
Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial.
Autorzy :
Devereux G; Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Wrolstad D; Precision for Medicine, Oncology and Rare Disease, Carlsbad, CA, United States of America.
Bourke SJ; Royal Victoria Infirmary, Newcastle, United Kingdom.
Daines CL; Banner University of Arizona Medical Center, Tucson, Arizona, United States of America.
Doe S; Royal Victoria Infirmary, Newcastle, United Kingdom.
Dougherty R; San Francisco Critical Care Medical Group California Pacific Medical Center, San Francisco, United States of America.
Franco R; The Medical College of Wisconsin/Froedtert Hospital, Milwaukee, Wisconsin, United States of America.
Innes A; Western General Hospital, Edinburgh, United Kingdom.
Kopp BT; Nationwide Children's Hospital, Columbus, OH, United States of America.
Lascano J; University of Florida, Gainesville, Florida, United States of America.
Layish D; Central Florida Pulmonary Group, Orlando, Florida, United States of America.
MacGregor G; Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Murray L; Raigmore Hospital, Inverness, United Kingdom.
Peckham D; St James's University Hospital, Leeds, United Kingdom.
Lucidi V; Ospedale Padiatrico Bambino Gesu Centro Fibrosi Cistica, Rome, Italy.
Lovie E; NovaBiotics Ltd, Aberdeen, United Kingdom.
Robertson J; NovaBiotics Ltd, Aberdeen, United Kingdom.
Fraser-Pitt DJ; NovaBiotics Ltd, Aberdeen, United Kingdom.
O'Neil DA; NovaBiotics Ltd, Aberdeen, United Kingdom.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Dec 28; Vol. 15 (12), pp. e0242945. Date of Electronic Publication: 2020 Dec 28 (Print Publication: 2020).
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Cysteamine/*administration & dosage
Cysteamine/*therapeutic use
Cystic Fibrosis/*drug therapy
Lung/*drug effects
Administration, Oral ; Adult ; Cysteamine/adverse effects ; Female ; Humans ; Male ; Medication Adherence ; Safety
Czasopismo naukowe
Tytuł :
I-152, a supplier of N-acetyl-cysteine and cysteamine, inhibits immunoglobulin secretion and plasma cell maturation in LP-BM5 murine leukemia retrovirus-infected mice by affecting the unfolded protein response.
Autorzy :
Fraternale A; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via Saffi 2, 61029 Urbino, Italy. Electronic address: .
Zara C; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via Saffi 2, 61029 Urbino, Italy.
Di Mambro T; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via Saffi 2, 61029 Urbino, Italy.
Manuali E; Laboratory of Histopathology and Clinical Chemistry, Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche 'Togo Rosati', 06126 Perugia, Italy.
Genovese DA; Laboratory of Histopathology and Clinical Chemistry, Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche 'Togo Rosati', 06126 Perugia, Italy.
Galluzzi L; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via Saffi 2, 61029 Urbino, Italy.
Diotallevi A; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via Saffi 2, 61029 Urbino, Italy.
Pompa A; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via Saffi 2, 61029 Urbino, Italy.
De Marchis F; CNR, Institute of Biosciences and Bioresources (IBBR), 06128 Perugia, Italy.
Ambrogini P; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via Saffi 2, 61029 Urbino, Italy.
Cesarini E; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via Saffi 2, 61029 Urbino, Italy.
Luchetti F; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via Saffi 2, 61029 Urbino, Italy.
Smietana M; Institut des Biomolécules Max Mousseron, Université de Montpellier UMR 5247 CNRS, ENSCM, 34095 Montpellier, France.
Green K; Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03766, USA.
Bartoccini F; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via Saffi 2, 61029 Urbino, Italy.
Magnani M; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via Saffi 2, 61029 Urbino, Italy.
Crinelli R; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via Saffi 2, 61029 Urbino, Italy.
Pokaż więcej
Źródło :
Biochimica et biophysica acta. Molecular basis of disease [Biochim Biophys Acta Mol Basis Dis] 2020 Dec 01; Vol. 1866 (12), pp. 165922. Date of Electronic Publication: 2020 Aug 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Acetylcysteine/*analogs & derivatives
Antiviral Agents/*pharmacology
Cysteamine/*analogs & derivatives
Immunoglobulins/*metabolism
Plasma Cells/*drug effects
Retroviridae Infections/*drug therapy
Tumor Virus Infections/*drug therapy
Unfolded Protein Response/*drug effects
Acetylcysteine/administration & dosage ; Acetylcysteine/pharmacology ; Animals ; Antiviral Agents/administration & dosage ; Cysteamine/administration & dosage ; Cysteamine/pharmacology ; Disease Models, Animal ; Female ; Immunoglobulins/blood ; Injections, Intraperitoneal ; Leukemia, Experimental/drug therapy ; Leukemia, Experimental/metabolism ; Leukemia, Experimental/virology ; Mice ; Mice, Inbred C57BL ; Plasma Cells/metabolism ; Plasma Cells/virology ; Protein Unfolding/drug effects ; Retroviridae Infections/metabolism ; Retroviridae Infections/virology ; Tumor Virus Infections/metabolism ; Tumor Virus Infections/virology
Czasopismo naukowe
Tytuł :
Chitotriosidase as a Novel Biomarker for Therapeutic Monitoring of Nephropathic Cystinosis.
Autorzy :
Veys KRP; Division of Pediatric Nephrology, Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, Katholieke Universiteit Leuven, Leuven, Belgium.
Elmonem MA; Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Van Dyck M; Division of Pediatric Nephrology, Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.
Janssen MC; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Cornelissen EAM; Department of Pediatric Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.
Hohenfellner K; Department of Pediatrics, Children's Hospital of Rosenheim, Rosenheim, Germany.
Prencipe G; Division of Rheumatology and Immuno-Rheumatology Research Laboratories, Bambino Gesù Children's Hospital, Rome, Italy.
van den Heuvel LP; Department of Development and Regeneration, Katholieke Universiteit Leuven, Leuven, Belgium.; Department of Pediatric Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.
Levtchenko E; Division of Pediatric Nephrology, Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium .; Department of Development and Regeneration, Katholieke Universiteit Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2020 May; Vol. 31 (5), pp. 1092-1106. Date of Electronic Publication: 2020 Apr 09.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Cysteamine/*therapeutic use
Cystinosis/*blood
Drug Monitoring/*methods
Hexosaminidases/*blood
Macrophage Activation/*drug effects
Adolescent ; Adult ; Biomarkers ; Child ; Cysteamine/pharmacology ; Cystine/blood ; Cystinosis/drug therapy ; Female ; Humans ; Inflammation ; Interleukin-18/blood ; Interleukin-1beta/blood ; Interleukin-6/blood ; Leukocytes/chemistry ; Male ; Medication Adherence ; Peptide Fragments/blood ; Prospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis.
Autorzy :
Hollywood JA; Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand .
Przepiorski A; Department of Developmental Biology, University of Pittsburgh, Pennsylvania.
D'Souza RF; Discipline of Nutrition, The University of Auckland, Auckland, New Zealand.
Sreebhavan S; Auckland Cancer Society Research Centre, The University of Auckland, Auckland, New Zealand.
Wolvetang EJ; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.
Harrison PT; Department of Physiology, Biosciences Institute, University College Cork, Cork, Ireland.
Davidson AJ; Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand.
Holm TM; Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand .
Pokaż więcej
Źródło :
Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2020 May; Vol. 31 (5), pp. 962-982. Date of Electronic Publication: 2020 Mar 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Disease Models, Animal*
Cysteamine/*therapeutic use
Cystinosis/*drug therapy
Everolimus/*therapeutic use
Induced Pluripotent Stem Cells/*transplantation
Organoids/*transplantation
TOR Serine-Threonine Kinases/*antagonists & inhibitors
Amino Acid Transport Systems, Neutral/deficiency ; Amino Acid Transport Systems, Neutral/genetics ; Animals ; Autophagy/drug effects ; CRISPR-Cas Systems ; Cell Line ; Cysteamine/pharmacology ; Cystine/blood ; Drug Evaluation, Preclinical ; Drug Therapy, Combination ; Everolimus/pharmacology ; Gene Editing ; Heterografts ; Humans ; Induced Pluripotent Stem Cells/metabolism ; Induced Pluripotent Stem Cells/ultrastructure ; Lysosomes/drug effects ; Lysosomes/ultrastructure ; Mice ; Mice, SCID ; Organoids/metabolism ; Phenotype
Czasopismo naukowe
Tytuł :
Ocular manifestations of intermediate cystinosis: To treat or not to treat?
Autorzy :
Sousa-Neves F; Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
Ribeiro AC; Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
Saraiva E; Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
Ribeiro L; Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
Sequeira J; Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
Varandas R; Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
Pokaż więcej
Źródło :
European journal of ophthalmology [Eur J Ophthalmol] 2020 Nov; Vol. 30 (6), pp. NP7-NP10. Date of Electronic Publication: 2019 May 10.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Visual Acuity*
Cornea/*pathology
Corneal Diseases/*etiology
Cysteamine/*therapeutic use
Cystinosis/*complications
Tomography, Optical Coherence/*methods
Adult ; Corneal Diseases/diagnosis ; Corneal Diseases/drug therapy ; Cystine Depleting Agents/therapeutic use ; Cystinosis/diagnosis ; Cystinosis/drug therapy ; Female ; Follow-Up Studies ; Humans ; Microscopy, Confocal/methods ; Slit Lamp Microscopy ; Time Factors
Czasopismo naukowe
Tytuł :
Rational Design of High-Performance Donor-Linker-Acceptor Hybrids Using a Schiff Base for Enabling Photoinduced Electron Transfer.
Autorzy :
Deng HH; Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Department of Pharmaceutical Analysis , Fujian Medical University , Fuzhou , Fujian 350004 , China.
Huang KY; Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Department of Pharmaceutical Analysis , Fujian Medical University , Fuzhou , Fujian 350004 , China.
He SB; Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Department of Pharmaceutical Analysis , Fujian Medical University , Fuzhou , Fujian 350004 , China.
Xue LP; Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Department of Pharmaceutical Analysis , Fujian Medical University , Fuzhou , Fujian 350004 , China.
Peng HP; Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Department of Pharmaceutical Analysis , Fujian Medical University , Fuzhou , Fujian 350004 , China.
Zha DJ; Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, School of Pharmacy , Fujian Medical University , Fuzhou , Fujian 350004 , China.
Sun WM; Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, School of Pharmacy , Fujian Medical University , Fuzhou , Fujian 350004 , China.
Xia XH; State Key Laboratory of Analytical Chemistry for Life Science and Collaborative Innovation Center of Chemistry for Life Sciences, School of Chemistry and Chemical Engineering , Nanjing University , Nanjing , Jiangsu 210093 , China.
Chen W; Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Department of Pharmaceutical Analysis , Fujian Medical University , Fuzhou , Fujian 350004 , China.
Pokaż więcej
Źródło :
Analytical chemistry [Anal Chem] 2020 Jan 21; Vol. 92 (2), pp. 2019-2026. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Acetylcysteine/*metabolism
Cysteamine/*metabolism
Gold/*metabolism
Metal Nanoparticles/*chemistry
Pyridoxal Phosphate/*metabolism
Acetylcysteine/chemistry ; Cysteamine/chemistry ; Density Functional Theory ; Electron Transport ; Gold/chemistry ; Particle Size ; Photochemical Processes ; Pyridoxal Phosphate/chemistry ; Schiff Bases/chemistry ; Schiff Bases/metabolism ; Surface Properties
Czasopismo naukowe
Tytuł :
Base-Sequence-Independent Efficient Redox Switching of Self-Assembled DNA Nanocages.
Autorzy :
Wang B; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
Song L; CAS Key Laboratory of Soft Matter Chemistry, Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026, P. R. China.
Jin B; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
Deng N; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
Wu X; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
He J; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
Deng Z; CAS Key Laboratory of Soft Matter Chemistry, Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026, P. R. China.
Li Y; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
Pokaż więcej
Źródło :
Chembiochem : a European journal of chemical biology [Chembiochem] 2019 Nov 04; Vol. 20 (21), pp. 2743-2746. Date of Electronic Publication: 2019 Sep 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Nucleic Acid Conformation*
Cystamine/*chemistry
Cysteamine/*chemistry
DNA/*chemistry
Nanostructures/*chemistry
Nanotechnology/*methods
Base Sequence ; Cystamine/metabolism ; Cysteamine/metabolism ; DNA/genetics ; DNA/metabolism ; Electrophoresis/methods ; Microscopy, Atomic Force ; Models, Chemical ; Molecular Structure ; Oxidation-Reduction
Czasopismo naukowe
Tytuł :
Compensation effects of coated cysteamine on meat quality, amino acid composition, fatty acid composition, mineral content in dorsal muscle and serum biochemical indices in finishing pigs offered reduced trace minerals diet.
Autorzy :
Bai M; National Engineering Laboratory for Pollution Control and Waste Utilization in Livestock and Poultry Production, Hunan Province Key Laboratory of Animal Nutritional Physiology and Metabolic Process, Hunan Provincial Engineering Research Center of Healthy Livestock, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, 410125, China.; College of Animal Science, South China Agricultural University, Guangzhou, 510642, China.
Liu H; National Engineering Laboratory for Pollution Control and Waste Utilization in Livestock and Poultry Production, Hunan Province Key Laboratory of Animal Nutritional Physiology and Metabolic Process, Hunan Provincial Engineering Research Center of Healthy Livestock, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, 410125, China. .; Hunan Co-Innovation Center of Animal Production Safety, Changsha, 410128, China. .
Xu K; National Engineering Laboratory for Pollution Control and Waste Utilization in Livestock and Poultry Production, Hunan Province Key Laboratory of Animal Nutritional Physiology and Metabolic Process, Hunan Provincial Engineering Research Center of Healthy Livestock, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, 410125, China.; Hunan Co-Innovation Center of Animal Production Safety, Changsha, 410128, China.
Zhang X; Hangzhou King Techina Technology Company Academician Expert Workstation, Hangzhou King Techina Technology Co., Ltd., Hangzhou, 311107, China.
Deng B; College of Animal Science, South China Agricultural University, Guangzhou, 510642, China.
Tan C; College of Animal Science, South China Agricultural University, Guangzhou, 510642, China.
Deng J; College of Animal Science, South China Agricultural University, Guangzhou, 510642, China. .
Bing P; Academics Working Station, Changsha Medical University, Changsha, 410219, China.
Yin Y; National Engineering Laboratory for Pollution Control and Waste Utilization in Livestock and Poultry Production, Hunan Province Key Laboratory of Animal Nutritional Physiology and Metabolic Process, Hunan Provincial Engineering Research Center of Healthy Livestock, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, 410125, China. .; College of Animal Science, South China Agricultural University, Guangzhou, 510642, China. .; Hunan Co-Innovation Center of Animal Production Safety, Changsha, 410128, China. .
Pokaż więcej
Źródło :
Science China. Life sciences [Sci China Life Sci] 2019 Nov; Vol. 62 (11), pp. 1550-1553. Date of Electronic Publication: 2019 Aug 15.
Typ publikacji :
Journal Article
MeSH Terms :
Animal Feed*
Food Quality*
Cysteamine/*metabolism
Meat/*analysis
Amino Acids/chemistry ; Animal Nutritional Physiological Phenomena ; Animals ; Cysteamine/chemistry ; Dietary Supplements ; Fatty Acids/chemistry ; Female ; Food, Formulated ; Male ; Minerals/chemistry ; Muscle, Skeletal/chemistry ; Swine ; Trace Elements/chemistry ; Trace Elements/metabolism ; Weight Gain
Czasopismo naukowe
Tytuł :
Influence of supplemented coated-cysteamine on morphology, apoptosis and oxidative stress status of gastrointestinal tract.
Autorzy :
Liu H; Scientific Observing and Experimental Station of Animal Nutrition and Feed Science in South-Central, Ministry of Agriculture, Hunan Provincial Engineering Research Center for Healthy Breeding of Livestock and Poultry, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, 644 Yuanda 2 Road, Changsha, 410125, China. .; Hangzhou King Techina Technology Company Academician Expert Workstation, Hangzhou King Techina Technology Co., Ltd., Hangzhou, 311107, China. .; Hunan Co-Innovation Center of Animal Production Safety, CICAPS, Changsha, Hunan, 410128, People's Republic of China. .
Bai M; Scientific Observing and Experimental Station of Animal Nutrition and Feed Science in South-Central, Ministry of Agriculture, Hunan Provincial Engineering Research Center for Healthy Breeding of Livestock and Poultry, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, 644 Yuanda 2 Road, Changsha, 410125, China.; College of Animal Science, South China Agricultural University, Guangzhou, 510642, Guangdong, China.
Tan B; Scientific Observing and Experimental Station of Animal Nutrition and Feed Science in South-Central, Ministry of Agriculture, Hunan Provincial Engineering Research Center for Healthy Breeding of Livestock and Poultry, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, 644 Yuanda 2 Road, Changsha, 410125, China.; College of Animal Science, South China Agricultural University, Guangzhou, 510642, Guangdong, China.
Xu K; Scientific Observing and Experimental Station of Animal Nutrition and Feed Science in South-Central, Ministry of Agriculture, Hunan Provincial Engineering Research Center for Healthy Breeding of Livestock and Poultry, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, 644 Yuanda 2 Road, Changsha, 410125, China.; Hangzhou King Techina Technology Company Academician Expert Workstation, Hangzhou King Techina Technology Co., Ltd., Hangzhou, 311107, China.
Yu R; Hangzhou King Techina Technology Company Academician Expert Workstation, Hangzhou King Techina Technology Co., Ltd., Hangzhou, 311107, China.
Huang R; Scientific Observing and Experimental Station of Animal Nutrition and Feed Science in South-Central, Ministry of Agriculture, Hunan Provincial Engineering Research Center for Healthy Breeding of Livestock and Poultry, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, 644 Yuanda 2 Road, Changsha, 410125, China.; Hangzhou King Techina Technology Company Academician Expert Workstation, Hangzhou King Techina Technology Co., Ltd., Hangzhou, 311107, China.
Yin Y; Scientific Observing and Experimental Station of Animal Nutrition and Feed Science in South-Central, Ministry of Agriculture, Hunan Provincial Engineering Research Center for Healthy Breeding of Livestock and Poultry, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, 644 Yuanda 2 Road, Changsha, 410125, China. .; Hangzhou King Techina Technology Company Academician Expert Workstation, Hangzhou King Techina Technology Co., Ltd., Hangzhou, 311107, China. .; College of Animal Science, South China Agricultural University, Guangzhou, 510642, Guangdong, China. .
Pokaż więcej
Źródło :
BMC veterinary research [BMC Vet Res] 2019 Sep 13; Vol. 15 (1), pp. 328. Date of Electronic Publication: 2019 Sep 13.
Typ publikacji :
Journal Article
MeSH Terms :
Dietary Supplements*
Apoptosis/*drug effects
Cysteamine/*pharmacology
Intestinal Mucosa/*drug effects
Animal Feed/analysis ; Animals ; Cysteamine/administration & dosage ; Diet/veterinary ; Ileum ; Intestinal Mucosa/metabolism ; Oxidative Stress/drug effects ; Sus scrofa
Czasopismo naukowe
Tytuł :
Cysteamine triggered "turn-on" fluorescence sensor for total detection of fumonisin B 1 , B 2 and B 3 .
Autorzy :
Zhang L; Grain and Oil Food Processing Key Laboratory of Jilin Province, Jilin Business and Technology College, Changchun 130507, China.
Sun Y; Grain and Oil Food Processing Key Laboratory of Jilin Province, Jilin Business and Technology College, Changchun 130507, China.
Liang X; College of Animal Sciences/ College of Life Science, Yangtze University, Jingzhou 434023, China.
Yang Y; College of Animal Sciences/ College of Life Science, Yangtze University, Jingzhou 434023, China.
Meng X; Grain and Oil Food Processing Key Laboratory of Jilin Province, Jilin Business and Technology College, Changchun 130507, China.
Zhang Q; Oil Crops Research Institute, Chinese Academy of Agricultural Sciences, Wuhan 430062, China; Laboratory of Quality & Safety Risk Assessment for Oilseed Products (Wuhan), Ministry of Agriculture, Wuhan 430062, China; Key Laboratory of Detection for Mycotoxins, Ministry of Agriculture, Wuhan 430062, China.
Li P; Oil Crops Research Institute, Chinese Academy of Agricultural Sciences, Wuhan 430062, China; Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture, Wuhan 430062, China; Laboratory of Quality & Safety Risk Assessment for Oilseed Products (Wuhan), Ministry of Agriculture, Wuhan 430062, China; Key Laboratory of Detection for Mycotoxins, Ministry of Agriculture, Wuhan 430062, China; Quality Inspection & Test Center for Oilseed Products, Ministry of Agriculture, Wuhan, 430062, China. Electronic address: .
Zhou Y; College of Animal Sciences/ College of Life Science, Yangtze University, Jingzhou 434023, China. Electronic address: .
Pokaż więcej
Źródło :
Food chemistry [Food Chem] 2020 Oct 15; Vol. 327, pp. 127058. Date of Electronic Publication: 2020 May 18.
Typ publikacji :
Journal Article
MeSH Terms :
Cysteamine/*chemistry
Fumonisins/*analysis
Spectrometry, Fluorescence/*methods
Food Contamination/analysis ; Gold/chemistry ; Limit of Detection ; Metal Nanoparticles/chemistry ; Rhodamines/chemistry ; Zea mays/chemistry ; Zea mays/metabolism
Czasopismo naukowe
Tytuł :
Highly recyclable cysteamine-modified acid-resistant MOFs for enhancing Hg (II) removal from water.
Autorzy :
Liu F; College of Public Health, Jilin University, Changchun, People's Republic of China.
Xiong W; College of Public Health, Jilin University, Changchun, People's Republic of China.
Feng X; College of Public Health, Jilin University, Changchun, People's Republic of China.
Cheng G; College of Public Health, Jilin University, Changchun, People's Republic of China.
Shi L; College of Public Health, Jilin University, Changchun, People's Republic of China.
Chen D; College of Public Health, Jilin University, Changchun, People's Republic of China.
Zhang Y; Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, People's Republic of China.
Pokaż więcej
Źródło :
Environmental technology [Environ Technol] 2020 Sep; Vol. 41 (23), pp. 3094-3104. Date of Electronic Publication: 2019 Apr 01.
Typ publikacji :
Journal Article
MeSH Terms :
Mercury*
Water Pollutants, Chemical*
Adsorption ; Cysteamine ; Water
Czasopismo naukowe
Tytuł :
Cysteamine as a novel disease-modifying compound for Parkinson's disease: Over a decade of research supporting a clinical trial.
Autorzy :
Cicchetti F; Département de Psychiatrie & Neurosciences, Faculté de Médecine, Université Laval, Québec G1V 0A6, QC, Canada; Centre de Recherche du CHU de Québec, Québec G1V 4G2, QC, Canada. Electronic address: .
David LS; Département de Psychiatrie & Neurosciences, Faculté de Médecine, Université Laval, Québec G1V 0A6, QC, Canada; Centre de Recherche du CHU de Québec, Québec G1V 4G2, QC, Canada.
Siddu A; Département de Psychiatrie & Neurosciences, Faculté de Médecine, Université Laval, Québec G1V 0A6, QC, Canada; Centre de Recherche du CHU de Québec, Québec G1V 4G2, QC, Canada.
Denis HL; Département de Psychiatrie & Neurosciences, Faculté de Médecine, Université Laval, Québec G1V 0A6, QC, Canada; Centre de Recherche du CHU de Québec, Québec G1V 4G2, QC, Canada.
Pokaż więcej
Źródło :
Neurobiology of disease [Neurobiol Dis] 2019 Oct; Vol. 130, pp. 104530. Date of Electronic Publication: 2019 Jul 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Cysteamine/*therapeutic use
Neuroprotective Agents/*therapeutic use
Parkinson Disease/*drug therapy
Clinical Trials as Topic ; Cysteamine/pharmacology ; Humans ; Neuroprotective Agents/pharmacology ; Oxidative Stress/drug effects
Czasopismo naukowe
Tytuł :
Management of bone disease in cystinosis: Statement from an international conference.
Autorzy :
Hohenfellner K; Ro Med Kliniken, Pediatric Nephrology, Rosenheim, Germany.
Rauch F; Shriners Hospital for Children, McGill University, Montreal, Canada.
Ariceta G; Service of Pediatric Nephrology, University Hospital Vall d' Hebron, Barcelona, Spain.
Awan A; Department of Nephrology, Children's University Hospital, Dublin, Ireland.
Bacchetta J; Référence Center for Rare Renal Diseases, Hôpital Femme-Mère-Enfant, Bron, France.
Bergmann C; Department of Medicine, University Hospital Freiburg, Freiburg, Germany.
Bechtold S; Division of Pediatric Endocrinology, Children's Hospital and Polyclinic iSPZ, Dr. v. Haunerschen Kinderspital, University Hospital Munich, Munich, Germany.
Cassidy N; Department of Orthopaedic Surgery, Children's University Hospital, Dublin, Ireland.
Deschenes G; Department of Pediatric Nephrology, Hôpital Robert-Debré and University of Paris Diderot, Paris, France.
Elenberg E; Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
Gahl WA; National Human Genome Research Institute, National Institutes of Health Undiagnosed Diseases Program, Bethesda, Maryland.
Greil O; Department of Diagnostic and Interventional Radiology, Klinikum Traunstein, Traunstein, Germany.
Harms E; Children's University Hospital Muenster, Muenster, Germany.
Herzig N; Schoen Clinic Munich Harlaching, Specialist Centre for Paediatric and Neuro-Orthopaedics, Munich, Germany.
Hoppe B; Division of Pediatric Nephrology, University Children's Hospital, Bonn, Germany.
Koeppl C; Kliniken Südostbayern AG, Sozialpädiatrisches Zentrum, Traunstein, Germany.
Lewis MA; Department of Nephrology, Children's University Hospital, Dublin, Ireland.
Levtchenko E; Department of Pediatrics & Development and Regeneration, University Hospitals Leuven & Katholieke Universiteit Leuven, Leuven, Belgium.
Nesterova G; National Institutes of Health, National Human Genome Research Institute (NHGRI), Bethesda, Maryland.
Santos F; Hospital Universitario Central de Asturias, Pediatría, Oviedo, Spain.
Schlingmann KP; Department of General Pediatrics, University Children's Hospital Münster, Münster, Germany.
Servais A; Reference Center of Inherited Metabolic Diseases, Nephrology Unit, Hospital Necker Enfants Malades, APHP, University Paris Descartes, Paris, France.
Soliman NA; Department of Pediatrics, Center of Pediatric Nephrology and Transplantation (CPNT), Kasr Al Ainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Steidle G; Kliniken Südostbayern AG, Sozialpädiatrisches Zentrum, Traunstein, Germany.
Sweeney C; Department of Nephrology, Children's University Hospital, Dublin, Ireland.
Treikauskas U; Department of Pediatrics, Department of Pediatric Nephrology, Ro-Med Kliniken, Rosenheim, Germany.
Topaloglu R; Department of Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Tsygin A; Department of Nephrology, National Medical and Research Center for Children's Health, Moscow, Russia.
Veys K; Department of Pediatrics & Development and Regeneration, University Hospitals Leuven & Katholieke Universiteit Leuven, Leuven, Belgium.
V Vigier R; Pediatric Clinic, Wildermeth Children's Hospital, Biel-Bienne, Switzerland.
Zustin J; Institute of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany.
Haffner D; Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany.
Pokaż więcej
Źródło :
Journal of inherited metabolic disease [J Inherit Metab Dis] 2019 Sep; Vol. 42 (5), pp. 1019-1029. Date of Electronic Publication: 2019 Aug 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Bone Diseases/*therapy
Cysteamine/*therapeutic use
Cystinosis/*drug therapy
Administration, Oral ; Bone Diseases/etiology ; Cysteamine/administration & dosage ; Cystinosis/complications ; Disease Management ; Fanconi Syndrome/drug therapy ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł :
Enhancing Tris(pyrazolyl)borate-Based Models of Cysteine/Cysteamine Dioxygenases through Steric Effects: Increased Reactivities, Full Product Characterization and Hints to Initial Superoxide Formation.
Autorzy :
Müller L; Institut für Chemie, Humboldt-Universität zu Berlin, Brook-Taylor-Straße 2, 12489, Berlin, Germany.
Hoof S; Institut für Chemie, Humboldt-Universität zu Berlin, Brook-Taylor-Straße 2, 12489, Berlin, Germany.
Keck M; Institut für Chemie, Humboldt-Universität zu Berlin, Brook-Taylor-Straße 2, 12489, Berlin, Germany.
Herwig C; Institut für Chemie, Humboldt-Universität zu Berlin, Brook-Taylor-Straße 2, 12489, Berlin, Germany.
Limberg C; Institut für Chemie, Humboldt-Universität zu Berlin, Brook-Taylor-Straße 2, 12489, Berlin, Germany.
Pokaż więcej
Źródło :
Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2020 Sep 10; Vol. 26 (51), pp. 11851-11861. Date of Electronic Publication: 2020 Aug 13.
Typ publikacji :
Journal Article
MeSH Terms :
Cysteamine/*chemistry
Cysteine/*chemistry
Cysteine Dioxygenase/*chemistry
Dioxygenases/*chemistry
Superoxides/*chemistry
Biomimetics ; Borates/chemistry ; Cobalt/chemistry ; Crystallography, X-Ray ; Cysteine Dioxygenase/metabolism ; Dioxygenases/metabolism ; Iron/chemistry ; Ligands ; Pyrazoles
Czasopismo naukowe
Tytuł :
A powerful combination of copper-cysteamine nanoparticles with potassium iodide for bacterial destruction.
Autorzy :
Zhen X; Department of Infectious Diseases, First Affiliated Hospital, Guangxi Medical University, Nanning 530021, China.
Chudal L; Department of Physics, The University of Texas at Arlington, Arlington, TX 76019-0059, USA.
Pandey NK; Department of Physics, The University of Texas at Arlington, Arlington, TX 76019-0059, USA.
Phan J; Department of Physics, The University of Texas at Arlington, Arlington, TX 76019-0059, USA.
Ran X; Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Amador E; Department of Physics, The University of Texas at Arlington, Arlington, TX 76019-0059, USA.
Huang X; Department of Physics, The University of Texas at Arlington, Arlington, TX 76019-0059, USA.
Johnson O; Department of Physics, The University of Texas at Arlington, Arlington, TX 76019-0059, USA.
Ran Y; Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Chen W; Department of Physics, The University of Texas at Arlington, Arlington, TX 76019-0059, USA. Electronic address: .
Hamblin MR; Department of Dermatology, Harvard Medical School, Boston, MA, USA.
Huang L; Department of Infectious Diseases, First Affiliated Hospital, Guangxi Medical University, Nanning 530021, China. Electronic address: .
Pokaż więcej
Źródło :
Materials science & engineering. C, Materials for biological applications [Mater Sci Eng C Mater Biol Appl] 2020 May; Vol. 110, pp. 110659. Date of Electronic Publication: 2020 Jan 11.
Typ publikacji :
Journal Article
MeSH Terms :
Bacteria/*drug effects
Copper/*pharmacology
Cysteamine/*pharmacology
Nanoparticles/*chemistry
Potassium Iodide/*pharmacology
Bacteria/radiation effects ; Escherichia coli/drug effects ; Escherichia coli/radiation effects ; Microbial Sensitivity Tests ; Microbial Viability/drug effects ; Nanoparticles/ultrastructure ; Photochemotherapy ; Reactive Oxygen Species/metabolism ; Staphylococcus aureus/drug effects ; Staphylococcus aureus/radiation effects ; Ultraviolet Rays
Czasopismo naukowe
Tytuł :
Effects of long-term cysteamine treatment in patients with cystinosis.
Autorzy :
Ariceta G; Pediatric Nephrology, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Barcelona, Spain. .; Servicio de Nefrología Pediátrica, Hospital Universitari Vall d' Hebron, Pg/ Vall d'Hebron 119-129, 08035, Barcelona, Spain. .
Giordano V; Orphan Europe, Puteaux, France.
Santos F; Hospital Universitario Central de Asturias & University of Oviedo, Oviedo, Spain.
Pokaż więcej
Źródło :
Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2019 Apr; Vol. 34 (4), pp. 571-578. Date of Electronic Publication: 2017 Dec 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Cysteamine/*administration & dosage
Cystine Depleting Agents/*administration & dosage
Cystinosis/*drug therapy
Amino Acid Transport Systems, Neutral/genetics ; Cysteamine/adverse effects ; Cystine Depleting Agents/adverse effects ; Cystinosis/complications ; Cystinosis/diagnosis ; Cystinosis/genetics ; Disease Progression ; Drug Administration Schedule ; Genetic Predisposition to Disease ; Humans ; Mutation ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis.
Autorzy :
Villella VR; European Institute for Research in Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy.
Esposito S; European Institute for Research in Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy.
Ferrari E; European Institute for Research in Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy.; Department of Health Sciences, University of Eastern Piedmont, Novara, 28100, Italy.
Monzani R; European Institute for Research in Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy.; Department of Health Sciences, University of Eastern Piedmont, Novara, 28100, Italy.
Tosco A; Regional Cystic Fibrosis Center, Pediatric Unit, Department of Translational Medical Sciences, Federico II University Naples, Naples, 80131, Italy.
Rossin F; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.
Castaldo A; Regional Cystic Fibrosis Center, Pediatric Unit, Department of Translational Medical Sciences, Federico II University Naples, Naples, 80131, Italy.
Silano M; Department of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Roma, Italy.
Marseglia GL; Dipartimento di Pediatria, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Romani L; Department of Experimental Medicine, University of Perugia, Perugia, Italy.
Barlev NA; Gene Expression Laboratory, Institute of Citology, Saint-Petersburg, Russia.
Piacentini M; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.
Raia V; Regional Cystic Fibrosis Center, Pediatric Unit, Department of Translational Medical Sciences, Federico II University Naples, Naples, 80131, Italy.
Kroemer G; Equipe11 labellisée Ligue Nationale contrele Cancer, Centre de Recherche des Cordeliers, Paris, France. .; INSERM U1138, Centre de Recherche des Cordeliers, Paris, France. .; Université Paris Descartes, Paris, France. .; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France. .; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. .; Suzhou Institute for Systems Biology, Chinese Academy of Sciences, Suzhou, China. .; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, 17176, Sweden. .
Maiuri L; European Institute for Research in Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy.; Department of Health Sciences, University of Eastern Piedmont, Novara, 28100, Italy.
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2019 Mar 15; Vol. 10 (4), pp. 258. Date of Electronic Publication: 2019 Mar 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autophagy/*drug effects
Cysteamine/*pharmacology
Cystic Fibrosis/*genetics
Cystic Fibrosis Transmembrane Conductance Regulator/*genetics
Cystic Fibrosis Transmembrane Conductance Regulator/*metabolism
Gliadin/*immunology
Peptide Fragments/*immunology
Animals ; Autophagy/genetics ; Beclin-1/genetics ; Beclin-1/metabolism ; Caco-2 Cells ; Cysteamine/therapeutic use ; Cystic Fibrosis/immunology ; Cystic Fibrosis Transmembrane Conductance Regulator/antagonists & inhibitors ; Cytokines/metabolism ; Epithelial Cells/drug effects ; Epithelial Cells/immunology ; Epithelial Cells/metabolism ; GTP-Binding Proteins/antagonists & inhibitors ; GTP-Binding Proteins/metabolism ; Gliadin/toxicity ; Heterozygote ; Homozygote ; Humans ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Peptide Fragments/toxicity ; Transglutaminases/antagonists & inhibitors ; Transglutaminases/metabolism
Czasopismo naukowe
Tytuł :
Investigation of copper-cysteamine nanoparticles as a new photosensitizer for anti-hepatocellular carcinoma.
Autorzy :
Huang X; a Department of Public Health School , Guangxi Medical University , Nanning , China.
Wan F; a Department of Public Health School , Guangxi Medical University , Nanning , China.
Ma L; b Department of Physics and the SAVANT Center , The University of Texas at Arlington , Arlington , TX , USA.
Phan JB; b Department of Physics and the SAVANT Center , The University of Texas at Arlington , Arlington , TX , USA.
Lim RX; b Department of Physics and the SAVANT Center , The University of Texas at Arlington , Arlington , TX , USA.
Li C; a Department of Public Health School , Guangxi Medical University , Nanning , China.
Chen J; a Department of Public Health School , Guangxi Medical University , Nanning , China.
Deng J; a Department of Public Health School , Guangxi Medical University , Nanning , China.
Li Y; c College of Global Public Health , New York University , New York , NY , USA.
Chen W; b Department of Physics and the SAVANT Center , The University of Texas at Arlington , Arlington , TX , USA.
He M; a Department of Public Health School , Guangxi Medical University , Nanning , China.; d Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University) , Ministry of Education , Nanning , P.R. China.; e Department of Animal Center , Guangxi Medical University , Nanning , China.
Pokaż więcej
Źródło :
Cancer biology & therapy [Cancer Biol Ther] 2019; Vol. 20 (6), pp. 812-825. Date of Electronic Publication: 2019 Feb 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Copper*/chemistry
Cysteamine*/chemistry
Metal Nanoparticles*/chemistry
Metal Nanoparticles*/ultrastructure
Antineoplastic Agents/*pharmacology
Photosensitizing Agents/*pharmacology
Animals ; Antineoplastic Agents/chemistry ; Carcinoma, Hepatocellular/drug therapy ; Carcinoma, Hepatocellular/metabolism ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Cell Survival/drug effects ; Cell Survival/radiation effects ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Exosomes/metabolism ; Humans ; Liver Neoplasms/drug therapy ; Liver Neoplasms/metabolism ; Liver Neoplasms/pathology ; Mice ; Photosensitizing Agents/chemistry ; Singlet Oxygen/metabolism ; Solubility ; Ultraviolet Rays ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo .
Autorzy :
Jeitner TM; Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY, USA .
Pinto JT; Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY, USA.
Cooper AJL; Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY, USA.
Pokaż więcej
Źródło :
Bioscience reports [Biosci Rep] 2018 Sep 05; Vol. 38 (5). Date of Electronic Publication: 2018 Sep 05 (Print Publication: 2018).
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cystamine/*pharmacology
Cysteamine/*analogs & derivatives
Cysteamine/*pharmacology
Enzyme Inhibitors/*pharmacology
Transglutaminases/*antagonists & inhibitors
Biomarkers/metabolism ; Cystamine/pharmacokinetics ; Cysteamine/pharmacokinetics ; Cysteine/metabolism ; Humans ; Oxidation-Reduction ; Transglutaminases/metabolism
Czasopismo naukowe
Tytuł :
An Infant With Vomiting, Constipation, and Weight Loss.
Autorzy :
Dixon AM; Tulane University, New Orleans, LA, USA.
Styres C; Louisiana State University, New Orleans, LA, USA.
Straatmann C; Louisiana State University, New Orleans, LA, USA.
Pokaż więcej
Źródło :
Clinical pediatrics [Clin Pediatr (Phila)] 2020 Jun; Vol. 59 (6), pp. 629-632. Date of Electronic Publication: 2020 Mar 22.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Weight Loss*
Constipation/*etiology
Fanconi Syndrome/*diagnosis
Vomiting/*etiology
Calcitriol/therapeutic use ; Citric Acid/therapeutic use ; Constipation/drug therapy ; Cysteamine/therapeutic use ; Cystinosis/diagnosis ; Cystinosis/drug therapy ; Cystinosis/etiology ; Diagnosis, Differential ; Fanconi Syndrome/complications ; Fanconi Syndrome/drug therapy ; Humans ; Infant ; Male ; Phosphorus/therapeutic use ; Potassium/therapeutic use ; Sodium/therapeutic use ; Sodium Citrate/therapeutic use ; Vomiting/drug therapy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies